Marinus Pharmaceuticals, Inc. earnings per share and revenue

MRNS earnings per share for the last quarter are -0.68 USD whereas the estimation was -0.66 USD which accounts for -2.61% surprise. Företagets omsättning för samma period uppgår till 7.68 M USD trots den uppskattade siffran 9.04 M USD. Estimated earnings per share for the next quarter are -0.59 USD, and revenue is expected to reach 9.55 M USD. Also watch annual changes over time to get a bigger picture of MRNS earnings per share and revenue dynamics.